生物合成的α-D-曼诺酶抑制剂 (-) - 斯旺森因
bioRxiv : the preprint server for biology
|October 10, 2024
概括
研究人员阐明了糖酶抑制剂 (-) - 斯温松因的生物合成. 他们发现了新的酶和机制,使生物催化合成新的相关化物.
科学领域:
- 自然产品生物合成 自然产品生物合成
- 酶学 是一种酶学.
- 有机化学 有机化学
背景情况:
- (-) - - 斯温索因是α-D-曼诺代酶的强有力的抑制剂,这是糖蛋白加工中的关键酶.
- 了解其生物合成是开发新型葡萄糖酶抑制剂的关键.
- 斯瓦宁素生产的自然途径在很大程度上仍未被描述.
研究的目的:
- 在体外和体内复制swainsonine生物合成途径.
- 阐明参与swainsonine形成的关键定制酶的机制.
- 为了使新的swainsonine类似物的生物催化合成.
主要方法:
- 生物合成途径的体内和体外复制.
- 对α-甲酸依赖的二氧化基酶 (SwnH1,SwnH2) 和胺缩酶 (SwnN) 的生物化学表征.
- 对酶立体特异性和区域选择性的分析,包括保护组的作用.
主要成果:
- 成功重建了swainsonine生物合成途径.
- 发现了一种涉及SwnH1和SwnH2二氧化原酶和SwnN胺还原酶的表皮化机制.
- 确定了一个O-乙烯基组作为可拆卸的保护/指导组,影响基化.
- 证明了SwnN的基质依赖的立体特异性.
结论:
- 这项研究揭示了类生物合成中的新型酶机制.
- 生物化学的洞察力促进了一个新的多氧化里胺类化合物的生物催化合成.
- 这项工作为各种葡萄糖酶抑制剂的生物合成铺平了道路.
相关概念视频
Biosynthesis of Polysaccharides
1
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
1
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Alkylation of β-Diester Enolates: Malonic Ester Synthesis
3.3K
Malonic ester synthesis is a method to obtain α substituted carboxylic acids from ꞵ-diesters such as diethyl malonate and alkyl halides.
3.3K
Drug Metabolism: Phase II Reactions
3.7K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.7K
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Biosynthesis in Bacteria
1
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1


